#umbilical #cord #banking #cost
FAQs: Stem Cell Banking at LifebankUSA
Public cord blood banking is free. The cost of cord blood banking with a private bank varies from company to company.
LifebankUSA has a range of pricing options across our banking services to meet your family’s individual needs. The cost of cord blood banking with LifebankUSA starts at $1,750 for enrollment, collection and processing, and the first year of storage. Thereafter, storage fees start at $125 a year (when prepaid for 25 years).
Our comprehensive banking options allow your family to take advantage of more of the benefits of both today’s and tomorrow’s stem‑cell‑based medical treatments. Adding placental blood, placental tissue, or cord blood tissue to your cord blood collection will be reflected in the associated costs. Learn more about our comprehensive banking services and their associated prices .
Ways to help manage the cost
To help your family manage the cost of cord blood banking and our other banking services, LifebankUSA offers several cost-saving programs, including:
- LifebankUSA Gift Registry : Receive contributions from friends and family members toward the cost of banking
- Refer a Friend, Get a Gift: For every person you refer who signs up and banks stem cells with LifebankUSA, you’ll receive a $150 Amazon gift card
- Bank Again at a Discount: Call for a discount on enrollment when you bank with us a second (or third!) time
How are stem cells processed?
When considering the cost of cord blood banking, it can be helpful to understand just where your money will go. LifebankUSA uses state-of-the-art collection, processing, and storage methods to help ensure that your baby’s stem cells are preserved for the long term, giving you immediate access if you should need them. LifebankUSA’s heparin-free collection process uses an FDA-recommended cell-protecting solution called citrate phosphate dextrose (CPD), which allows cells to maintain their integrity in the time between collection and processing.
LifebankUSA removes red blood cells, which have no therapeutic benefit and can lead to transplant complications 13. from cord blood through a customized process called “red blood cell depletion”.
Our process ensures that the cord blood units are 99% pure* on average. 14 Our trained technicians manually separate red blood cells from stem cells, giving your collection the personalized attention it deserves. Other cord blood banks use an automated process and may have purity levels as low as 71%. 15,16
*Purity is defined as the absence of red blood cells in cord blood.
- National Institutes of Health. Stem cell basics: 1. Introduction. Available at: https://stemcells.nih.gov/info/basics/1.htm. Accessed Jan. 11, 2017.
- National Institutes of Health. Stem cell basics: frequently asked questions (FAQs). Available at: https://stemcells.nih.gov/info/faqs.htm. Accessed Jan. 19, 2017.
- Weiss M and Troyer DL. Stem Cells in the Umbilical Cord. Stem Cell Rev. 2006; 2(2):155–162.
- Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored Placental Blood for Unrelated Bone Marrow Reconstitution. Blood. 1993; 81(7):1679-1690.
- National Institutes of Health. Regenerative Medicine: 2. Bone Marrow (Hematopoietic) Stem Cells. Available at: https://stemcells.nih.gov/info/Regenerative_Medicine/2006Chapter2.htm. Accessed Jan. 19, 2017.
- Moise K Jr. Umbilical cord stem cells. Obstet Gynecol. 2005;106(6):1393-1407.
- Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles, Ligaments and Tendons Journal 2012; 2(3):154-162.
- National Institutes of Health. Mesenchymal Stem Cells. ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/results?term=mesenchymal+stem+cells Search=Search. Accessed Jan. 19, 2017.
- U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). Learn About Transplantation as a Treatment Option. Available at: https://bloodcell.transplant.hrsa.gov/transplant/understanding_tx/index.html#Treatment. Accessed on Jan. 18, 2017.
- The Leukemia Lymphoma Society. Cord Blood Stem Cell Transplantation. 2007. Available at https://www.lls.org/sites/default/files/file_assets/cordbloodstemcelltransplantation.pdf. Accessed on Jan. 18, 2017.
- St. Baldrick’s Foundation. New Data Shows a Child Is Diagnosed With Cancer Every 2 Minutes. Available at: http://www.stbaldricks.org/blog/post/new-data-shows-a-child-is-diagnosed-with-cancer-every-2-minutes/. Accessed Jan. 11, 2017.
- Nietfeld J. Lifetime probabilities of hematopoietic stem cells transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316–322.
- Parent’s Guide to Cord Blood Foundation. Why red blood cells should be removed before cord blood storage. Available at: https://parentsguidecordblood.org/en/news/why-red-blood-cells-should-be-removed-cord-blood-storage. Accessed Jan. 19, 2016.
- Data on file, LifebankUSA; 2010.
- Henderson C, Wofford J, Fortune F, Regan D. Evaluation of Processing Technologies for Umbilical Cord Blood (UCB). Poster presented at: ISCT Annual Meeting; May 2010; Philadelphia, PA.
- Dobrila L, Chapman J, Marr D, Kumar V, Coelho P, Rubinstein P. ThermoGenesis AXP AutoXpress™ Platform and BioArchive™ System for Automated Cord Blood Banking. Poster presented at: XXIXth International Congress of the International Society of Blood Transfusion; September 2006; Cape Town, South Africa.
- Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol. 2006; 18(5):565-570.
- Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transpl. 2006;38(2):83-93.
- Kamani N, Spellman S, Hurley CK, et al. State of the Art Review: HLA Matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants. Biol Blood Marrow Tr. 2008; 14(1):1-6.
- Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A. Mesenchymal Stem Cells in Regenerative Medicine: Opportunities and Challenges for Articular Cartilage and Intervertebral Disc Tissue Engineering. J Cell Physiol. 2010; 222(1):23-32.
- Yen BL, Huang H-I, Chien C-C, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005; 23(1):3-9.
- daSilva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26(9):2287-2299.
- Rabe H, Diaz-Rossello JL, Duley L, Dowswell T. Effect of timing of umbilical cord clamping and strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2012;8(CD003248).
- McDonald SJ, Middleton P, Dowswell T, Morris PS. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev. 2008;2(CD004074).
- Allan DS, Scrivens N, Lawless T, Mostert K, Oppenheimer L, Walker M, Petraszko T, Elmoazzen H. Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking. Transfusion 2016;56(3);662-665.
- Sommers R, Stonestreet BS, Oh W, Laptook A, Yanowitz TD, Raker C, Mercer J. Hemodynamic Effects of Delayed Cord Clamping in Premature Infants. Pediatrics. 2012;129(3):e667–e672.
- Delayed umbilical cord clamping after birth. Committee Opinion No. 684. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;129:e5–10.
- Parent’s Guide to Cord Blood Foundation. Timing of Umbilical Cord Clamping and Impact on Cord Blood Volume Collected for Banking. Available at http://parentsguidecordblood.org/en/news/timing-umbilical-cord-clamping-and-impact-cord-blood-volume-collected-banking. Accessed on Jan. 19, 2017.
- The Bone Marrow Foundation. Become a bone marrow/stem cell donor. Available at: http://bonemarrow.org/help/become-a-donor/. Accessed Jan. 11, 2017.
45 Horsehill Road
Cedar Knolls, NJ 07927
We’re here to help!
Customer service hours
Monday to Friday: 8am 8pm EST
Saturday: 9am 3pm EST
All Rights Reserved.